Chemcon Speciality

₹247 -1.8 | 0.7%

WEBSITE BSE:543233 NSE : CHEMCON 10 May, 16:01

Market Cap ₹905 Cr.

Stock P/E 33.8

P/B 1.9

Current Price ₹247

Book Value ₹ 129.3

Face Value 10

52W High ₹319.1

Dividend Yield 1.62%

52W Low ₹ 230

Edit Ratio

Chemcon Speciality Research see more...

Overview Inc. Year: 1988Industry: Chemicals

Chemcon Speciality Chemicals Ltd engages within the manufacture and sale of pharmaceutical intermediates, silanes, and oilfield chemical compounds in India. It offers oilfield chemical substances, which include calcium bromide liquids, calcium bromide powders, sodium bromide solutions, and zinc bromide solutions; pharmaceutical chemical, which include hexamethyl disilazanes, chloromethyl isopropyl carbonates, trimethyl chlorosilanes, and hexamethyl disiloxanes; and Silanes comprising hexamethyl disilazanes, trimethyl chlorosilanes, and hexamethyl disiloxanes, in addition to provides contract manufacturing offerings. The company additionally exports its merchandise to United States, Italy, South Korea, Germany, the People’s Republic of China, Japan, the United Arab Emirates, Serbia, Russia, Spain, Thailand, and Malaysia. The enterprise become integrated in 1988 and is situated in Vadodara, India.

Chemcon Speciality Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Chemcon Speciality Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	61	50	89	89	58	76	79	79	75	53
Other Income	2	2	3	3	3	4	3	4	3	3
Total Income	63	52	92	92	61	81	82	83	78	56
Total Expenditure	42	32	62	56	48	63	65	72	67	47
Operating Profit	21	20	30	36	13	18	17	11	11	10
Interest	0	0	0	0	0	1	0	1	1	1
Depreciation	2	2	2	2	2	2	2	3	3	3
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	20	18	28	34	11	15	14	8	8	6
Provision for Tax	5	5	7	9	3	4	4	2	2	2
Profit After Tax	15	13	21	25	8	11	10	6	6	4
Adjustments	-0	0	0	0	-0	0	0	0	0	0
Profit After Adjustments	15	13	21	25	8	11	10	6	6	4
Adjusted Earnings Per Share	4	3.7	5.8	6.9	2.1	3.1	2.9	1.6	1.6	1.2

Chemcon Speciality Profit & Loss

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	90	158	303	262	243	257	303	286
Other Income	0	0	2	4	5	9	13	13
Total Income	90	158	305	266	248	266	316	299
Total Expenditure	81	113	237	192	162	176	232	251
Operating Profit	9	46	68	74	86	91	84	49
Interest	2	3	4	5	4	1	1	3
Depreciation	2	2	3	5	6	6	8	11
Exceptional Income / Expenses	0	0	0	0	0	0	0	0
Profit Before Tax	4	41	61	65	76	84	74	36
Provision for Tax	2	14	18	16	20	21	19	10
Profit After Tax	3	26	43	49	56	63	55	26
Adjustments	0	0	0	0	0	0	0	0
Profit After Adjustments	3	26	43	49	56	63	55	26
Adjusted Earnings Per Share	0	0	0	15.4	15.4	17.1	15	7.3

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	18%	5%	14%	0%
Operating Profit CAGR	-8%	4%	13%	0%
PAT CAGR	-13%	4%	16%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-10%	-18%	NA%	NA%
ROE Average	13%	17%	30%	32%
ROCE Average	16%	22%	35%	37%

Chemcon Speciality Balance Sheet

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	27	54	97	146	354	417	457
Minority's Interest	0	0	0	0	0	0	0
Borrowings	2	2	2	15	2	1	1
Other Non-Current Liabilities	2	2	3	3	8	3	4
Total Current Liabilities	32	39	71	62	40	78	91
Total Liabilities	63	97	173	226	404	498	553
Fixed Assets	24	30	40	49	67	82	141
Other Non-Current Assets	2	2	2	4	52	40	101
Total Current Assets	37	65	131	173	285	376	311
Total Assets	63	97	173	226	404	498	553

Chemcon Speciality Cash Flow

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	1	1	1	1	1	24	36
Cash Flow from Operating Activities	2	14	11	12	65	74	13
Cash Flow from Investing Activities	-8	-7	-24	-16	-152	-93	-16
Cash Flow from Financing Activities	5	-6	12	4	111	30	12
Net Cash Inflow / Outflow	-0	1	-0	0	23	11	8
Closing Cash & Cash Equivalent	1	1	1	1	24	36	44

Chemcon Speciality Ratios

#	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	0	8.3	13.54	15.37	15.4	17.13	15.04
CEPS(Rs)	1.62	9.01	14.45	16.83	17.06	18.84	17.33
DPS(Rs)	0	0	0	0	0	0	4
Book NAV/Share(Rs)	0	16.88	30.53	46.06	96.56	113.89	124.86
Core EBITDA Margin(%)	9.63	28.86	21.78	26.81	33.32	31.74	23.34
EBIT Margin(%)	7.15	27.53	21.5	26.56	32.73	32.89	24.97
Pre Tax Margin(%)	4.93	25.62	20.18	24.77	31.24	32.67	24.48
PAT Margin (%)	3.14	16.66	14.19	18.64	23.16	24.41	18.2
Cash Profit Margin (%)	5.74	18.09	15.13	20.41	25.66	26.85	20.96
ROA(%)	4.51	33.03	31.87	24.5	17.92	13.92	10.48
ROE(%)	10.44	65.4	57.14	40.14	22.56	16.28	12.6
ROCE(%)	13.6	74.02	64.99	43.37	29.01	20.85	15.53
Receivable days	90.9	59.88	56.36	106.6	137.7	140.02	102.49
Inventory Days	36.71	34.67	40.28	65.46	80.23	66.43	68.49
Payable days	54.45	61.03	45.54	66.91	71.75	68.17	46.99
PER(x)	0	0	0	0	26.47	15.56	15.24
Price/Book(x)	0	0	0	0	4.22	2.34	1.84
Dividend Yield(%)	0	0	0	0	0	0	1.74
EV/Net Sales(x)	0.3	0.15	0.18	0.24	5.65	3.06	2.55
EV/Core EBITDA(x)	3.11	0.51	0.78	0.84	16.04	8.67	9.2
Net Sales Growth(%)	0	76.11	91.62	-13.61	-7.08	5.6	17.8
EBIT Growth(%)	0	578.19	49.6	6.75	14.48	6.12	-10.55
PAT Growth(%)	0	834.17	63.15	13.5	15.45	11.27	-12.18
EPS Growth(%)	0	834.17	63.14	13.5	0.15	11.27	-12.18
Debt/Equity(x)	0.75	0.32	0.34	0.3	0.01	0.09	0.14
Current Ratio(x)	1.16	1.7	1.86	2.8	7.08	4.84	3.41
Quick Ratio(x)	0.87	1.15	1.21	2.02	5.61	4.4	2.55
Interest Cover(x)	3.22	14.36	16.3	14.86	21.93	148.52	50.81
Total Debt/Mcap(x)	0	0	0	0	0	0.04	0.08

Chemcon Speciality Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	74.47	74.47	74.47	74.47	74.47	74.47	74.47	74.47	74.47	74.47
FII	0.02	0.05	0.02	0.14	0.01	0.1	0.01	0.01	0.05	0.25
DII	0.68	0.27	0.27	0.27	0.27	0.27	0.27	0.27	0.28	0.27
Public	24.83	25.21	25.24	25.12	25.25	25.16	25.25	25.25	25.2	25.01
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	2.73	2.73	2.73	2.73	2.73	2.73	2.73	2.73	2.73	2.73
FII	0	0	0	0.01	0	0	0	0	0	0.01
DII	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Public	0.91	0.92	0.92	0.92	0.92	0.92	0.92	0.92	0.92	0.92
Others	0	0	0	0	0	0	0	0	0	0
Total	3.66	3.66	3.66	3.66	3.66	3.66	3.66	3.66	3.66	3.66

Pros

Debtor days have improved from 68.17 to 46.99days.
Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.